Regulations And Regulatory Bodies - NAPLEX

Up to $5$ refills within $6$ months. This restriction balances access for medical needs with controls to minimize abuse and diversion risks.

Maintain records for at least $2$ years. This duration facilitates regulatory audits and compliance checks for controlled substances.

Within $7$ days. This requirement ensures timely documentation to verify the legitimacy of emergency dispensations.

Maximum $72$-hour supply. This limit provides immediate relief in urgent situations while mandating follow-up for accountability.

No federal expiration; follow state law and professional judgment. Federal guidelines defer to state-specific rules and pharmacist discretion to ensure safe dispensing.

No refills permitted. This policy tightly controls high-abuse substances by requiring new prescriptions for continued therapy.

$6$ months from date written. This timeframe ensures prescriptions are filled promptly while allowing flexibility for patient needs.

Initial inventory and at least every $2$ years thereafter. This schedule detects losses or discrepancies in controlled substance stocks for regulatory compliance.

DEA Form $222$. This form ensures secure, tracked ordering of high-risk substances to prevent diversion.

DEA Form $106$. This form enables prompt reporting and investigation of losses to maintain inventory integrity.

Schedules III–V once; Schedule II transfers generally not permitted. These rules limit transfers to reduce diversion risks while allowing some flexibility for lower schedules.

OBRA ’90. This act mandates counseling offers to enhance patient education and medication safety in outpatient care.

Kefauver–Harris Amendments of 1962. Enacted post-thalidomide, this amendment mandated efficacy evidence and improved clinical trial consent processes.

Biologics Price Competition and Innovation Act (BPCIA) of 2009. This act established approval pathways for biologics and biosimilars to promote innovation and affordability.

HIPAA Privacy Rule. This regulation sets standards for handling PHI to protect patient confidentiality in healthcare.

HITECH Act breach notification requirements. This act strengthens HIPAA by requiring notifications to promote accountability after data breaches.

Follow the more stringent law. Adhering to the stricter standard ensures optimal compliance and public safety protection.

Schedule I. This classification denotes substances with no recognized medical value and significant risk of abuse under federal law.

Controlled Substances Act of 1970. This legislation classified drugs into schedules based on their potential for abuse and medical utility.

National Association of Boards of Pharmacy (NABP). This organization develops and administers standardized competency exams for pharmacist licensure across states.

Licensure and discipline of pharmacists and pharmacies. State boards ensure professional standards by granting licenses and imposing penalties for violations.

Drug Enforcement Administration (DEA). This agency oversees the regulation and enforcement of controlled substances to prevent diversion and abuse in pharmaceutical settings.

Schedule II. This category includes substances with legitimate medical applications but high potential for severe physical or psychological dependence.